PreveCeutical Medical Inc.
PREV
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -172.60K | -246.20K | -264.50K | -174.60K | -311.00K |
| Total Depreciation and Amortization | 1.80K | 1.90K | 1.80K | 1.90K | 1.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 106.90K | 63.80K | 57.90K | 58.60K | 89.40K |
| Change in Net Operating Assets | 16.70K | 98.60K | 65.50K | 70.80K | 192.40K |
| Cash from Operations | -47.10K | -81.90K | -139.30K | -43.30K | -27.30K |
| Capital Expenditure | -500.00 | -100.00 | -100.00 | -600.00 | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -500.00 | -100.00 | -100.00 | -600.00 | -- |
| Total Debt Issued | 83.20K | 22.80K | 156.00K | 60.40K | 37.20K |
| Total Debt Repaid | -1.50K | -1.00K | -72.00K | -- | -- |
| Issuance of Common Stock | 43.90K | 90.00K | 105.80K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 89.70K | 82.00K | 138.70K | 44.80K | 27.30K |
| Foreign Exchange rate Adjustments | -100.00 | 100.00 | -1.20K | 100.00 | -200.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.10K | 0.00 | -1.90K | 1.00K | -200.00 |